Journal of Internal Medicine, 2015
Decreased levels of stem cell factor in subjects with incident coronary events

Wigren M., Rattik S., Hultman K. et al.

Thrombosis Research, 2015
Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction

Helseth R., Weiss T., Opstad T. et al.

Diabetes, 2015
Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts

Nowak C., Sundström J., Gustafsson S. et al.

Stroke, 2015
Fibroblast Growth Factor 23 and Incidence of Subarachnoid Hemorrhage

Söderholm M., Engström G.

Cytokine, 2015
The body mass index (BMI) is significantly correlated with levels of cytokines and chemokines in cerebrospinal fluid

Larsson A., Carlsson L., Lind A. et al.

Clinical Cancer Research, 2015
Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting

Chen H., Zucknick M., Werner S. et al.

Biomolecular Detection and Quantification, 2015
Proximity assays for sensitive quantification of proteins

Greenwood C., Ruff D., Kirvell S. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2015
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes

Goncalves I., Bengtsson E., Colhoun H. et al.

Molecular Cancer Therapeutics, 2015
The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

Christiansson L., Söderlund S., Mangsbo S. et al.

Arteriosclerosis, Thrombosis, and Vascular Biology, 2014
High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events

Rattik S., Wigren M., Björkbacka H. et al.

Brain, Behavior, and Immunity, 2014
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment

Isgren A., Jakobsson J., Pålsson E. et al.

Nature Communications, 2014
Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs

Enroth S., Johansson ?., Enroth S. et al.

PLoS ONE, 2014
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

Assarsson E., Lundberg M., Holmquist G. et al.

Atherosclerosis, 2025
Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals – an observational cross-sectional study

Cederström S., Wang Y., Lundman P. et al.

Frontiers in Immunology, 2025
Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling

Bhandage A., Punga A.

ESMO Open, 2025
Tislelizumab plus nab-paclitaxel and cisplatin as induction immunochemotherapy for organ preservation of locally advanced hypopharyngeal squamous cell carcinoma: a single-arm phase II trial

Gui L., Xie Z., Zhang W. et al.

Clinical Cancer Research, 2025
First-in-Human Phase 1/2 Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Hamid O., Cardin D., Hodi F. et al.

Translational Psychiatry, 2025
Exosomes from high-altitude cerebral edema patients induce cognitive dysfunction by altering oxidative stress responses in mice

Fu Q., Qiu R., Tang Q. et al.

eBioMedicine, 2025
The influence of metformin treatment on the circulating proteome

Connolly B., McCreight L., Slieker R. et al.

American Journal of Respiratory and Critical Care Medicine, 2025
Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4)

Hull R., Stobo J., Abo-Leyah H. et al.